Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal necrotizing enterocolitis: an overview.

Dimitris A Kafetzis1, Chrysanthi Skevaki, Christos Costalos

  • 1University of Athens, Second Department of Pediatrics, P. & A. Kyriakou Children's Hospital, Greece. kafetzis@ath.forthnet.gr

Current Opinion in Infectious Diseases
|July 16, 2003
PubMed
Summary

Necrotizing enterocolitis (NEC) is a severe condition in premature infants. Early diagnosis and novel preventive strategies, including probiotics and advanced imaging, show promise for improving survival rates in affected neonates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of geomagnetic disturbances on mortality from respiratory tract infections in the USA, 2000-2019.

Journal of exposure science & environmental epidemiology·2026
Same author

Climate change-associated heat extremes and immune dysregulation: emerging links with autoimmunity, allergy, and infectious diseases.

Seminars in immunopathology·2026
Same author

Early neutrophil and persistent eosinophil-associated gene signature in childhood asthma.

American journal of respiratory and critical care medicine·2026
Same author

Immunosenescence and susceptibility to respiratory viruses: a state-of-the-art review.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Playgrounds as microbial interfaces: strategies to enhance soil microbiomes and support healthy childhoods.

mSystems·2026
Same author

The CARMUCI Study Design: A Double-Blind, Cross-Over Sham-Controlled Trial of Indoor Air Purification in People With Cystic Fibrosis and Primary Ciliary Dyskinesia.

Pediatric pulmonology·2026

Area of Science:

  • Neonatal medicine
  • Gastroenterology
  • Pediatric surgery

Background:

  • Necrotizing enterocolitis (NEC) is a significant cause of mortality in premature infants, with unclear etiology.
  • Affects up to 28% of very low birthweight infants, posing a major clinical challenge.
  • Current management and research focus on improving outcomes for affected neonates.

Purpose of the Study:

  • To review current diagnostic tools and preventive strategies for necrotizing enterocolitis.
  • To explore recent advances in the management of necrotizing enterocolitis in neonates.
  • To stimulate further research into the diagnosis and treatment of this condition.

Main Methods:

  • Review of current diagnostic techniques including imaging (radiography, ultrasonography, MRI), gastrointestinal tonometry, biochemical markers, and breath analysis.

Related Experiment Videos

  • Evaluation of emerging preventive strategies such as enhanced platelet-activating factor acetyl hydrolase activity, receptor antagonists, and probiotics (Bifidobacterium infantis, Lactobacillus acidophilus).
  • Assessment of novel treatment options, including oxygenated perfluorocarbon.
  • Main Results:

    • Various diagnostic methods are available, offering potential for earlier detection of necrotizing enterocolitis.
    • Promising preventive strategies include specific probiotics and interventions targeting platelet-activating factor.
    • Oxygenated perfluorocarbon represents a new therapeutic option for necrotizing enterocolitis.

    Conclusions:

    • Early diagnosis and prevention are crucial for combating necrotizing enterocolitis.
    • Clinical and experimental advances presented aim to enhance survival rates for infants with necrotizing enterocolitis.
    • Continued research is essential to further improve the management of this devastating neonatal disease.